Pharmacokinetics, dose adjustments, and 6‐mercaptopurine/ methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency

This publication has 13 references indexed in Scilit:

• Thiopurine Methyltransferase Pharmacogenetics: Human Gene Cloning and Characterization of a Common Polymorphism
  DNA and Cell Biology, 1996
• Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
  Journal of Clinical Oncology, 1995
• Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia
  The Lancet, 1994
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
  Archives of Disease in Childhood, 1993
• Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient
  The Lancet, 1993
• Studies Strategies and Design
  Journal of Pediatric Hematology/Oncology, 1993
• Methylation pharmacogenetics: Thiopurine methyltransferase as a model system
  Xenobiotica, 1992
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia
  The Journal of Pediatrics, 1991
• Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiourie acid in biological fluids by high-performance liquid chromatography: Technical Note
  Scandinavian Journal of Clinical and Laboratory Investigation, 1989
• Variable Bioavailability of Oral Mercaptopurine
  New England Journal of Medicine, 1983